作者:
关键词
Anti-PD-1-antibodyCTLA-4, Cytotoxic T-lymphocyte-associated antigen 4ICIs, Immune checkpoint inhibitorsImmune checkpoint inhibitorsIsolated ACTH deficiencyLung cancerNivolumabPD-1, Programmed death 1PD-L1, Programmed cell death ligand-1PD-L2, Programmed cell death ligand-2irAEs, Immune-related adverse events
DOI
10.1016/j.rmcr.2019.01.021
PMID
30740300
发布时间
2022-03-31
- 浏览4
Respiratory medicine case reports
2019年26卷
223-226页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文